Prognostic impact of pneumonitis after durvalumab therapy in patients with locally advanced non-small cell lung cancer

Background. Prognostic data on Japanese patients receiving durvalumab after chemoradiotherapy (CRT) for locally advanced non-small cell lung cancer (LA-NSCLC) are insufficient. Whether pneumonitis has prognostic implications in patients with LA-NSCLC who have received durvalumab also remains unclear...

Descripción completa

Detalles Bibliográficos
Autores principales: Nishimura, Ari, Ono, Akira, Wakuda, Kazushige, Kawabata, Takanori, Yabe, Michitoshi, Miyawaki, Taichi, Miyawaki, Eriko, Kodama, Hiroaki, Nishioka, Naoya, Mamesaya, Nobuaki, Kobayashi, Haruki, Omori, Shota, Kenmotsu, Hirotsugu, Naito, Tateaki, Murakami, Haruyasu, Harada, Hideyuki, Takahashi, Toshiaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2021
Materias:
Short Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8993741/
https://www.ncbi.nlm.nih.gov/pubmed/34633575
http://dx.doi.org/10.1007/s10637-021-01191-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8993741/
https://www.ncbi.nlm.nih.gov/pubmed/34633575
http://dx.doi.org/10.1007/s10637-021-01191-6

Ejemplares similares